Results 251 to 260 of about 235,517 (308)
Nanoengineered photosensitizers for photodynamic priming to overcome P-glycoprotein-mediated multidrug resistance. [PDF]
Rahman I +7 more
europepmc +1 more source
Terpenoids: Emerging Natural Modulators for Reversing ABC Transporter-Mediated Multidrug Resistance in Cancer Chemotherapy. [PDF]
Ma L +8 more
europepmc +1 more source
A study of genomic complexity underlying multidrug resistance in Candida auris strains in Thailand. [PDF]
Opassathian K +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Breast Cancer Research and Treatment, 1984
Mutations resulting in a complex phenotype of cross-resistance and collateral-sensitivity are frequently observed in mammalian cell lines. A cell surface 170 000 dalton glycoprotein (P-glycoprotein) has been identified to be intimately associated with this multidrug resistance phenotype.
V, Ling, J, Gerlach, N, Kartner
openaire +2 more sources
Mutations resulting in a complex phenotype of cross-resistance and collateral-sensitivity are frequently observed in mammalian cell lines. A cell surface 170 000 dalton glycoprotein (P-glycoprotein) has been identified to be intimately associated with this multidrug resistance phenotype.
V, Ling, J, Gerlach, N, Kartner
openaire +2 more sources
Anti-Cancer Drugs, 1995
Since we found verapamil as a multidrug resistance (MDR) reversing agent in 1981, many MDR reversing compounds have been reported. This type of drug must have strong effects with little side effects. We recently found MS-209 and PSC-833 as reversing agents.
T, Tsuruo, A, Tomida
openaire +2 more sources
Since we found verapamil as a multidrug resistance (MDR) reversing agent in 1981, many MDR reversing compounds have been reported. This type of drug must have strong effects with little side effects. We recently found MS-209 and PSC-833 as reversing agents.
T, Tsuruo, A, Tomida
openaire +2 more sources

